Algernon Pharmaceuticals Valuation
| AGNPF Stock | USD 0.06 0.01 12.55% |
Algernon Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Algernon Pharmaceuticals from analyzing the firm fundamentals such as return on equity of -1.09, and Current Valuation of 3.03 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Algernon Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Algernon Pharmaceuticals is based on 3 months time horizon. Increasing Algernon Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Algernon otc stock is determined by what a typical buyer is willing to pay for full or partial control of Algernon Pharmaceuticals. Since Algernon Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Algernon OTC Stock. However, Algernon Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0574 | Real 0.0518 | Hype 0.06 | Naive 0.0553 |
The real value of Algernon OTC Stock, also known as its intrinsic value, is the underlying worth of Algernon Pharmaceuticals OTC Stock, which is reflected in its stock price. It is based on Algernon Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Algernon Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Algernon Pharmaceuticals helps investors to forecast how Algernon otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Algernon Pharmaceuticals more accurately as focusing exclusively on Algernon Pharmaceuticals' fundamentals will not take into account other important factors: Algernon Pharmaceuticals Total Value Analysis
Algernon Pharmaceuticals is presently projected to have takeover price of 3.03 M with market capitalization of 3.96 M, debt of 0, and cash on hands of 872.84 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Algernon Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.03 M | 3.96 M | 0 | 872.84 K |
Algernon Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Algernon is to check how much profit was generated for every dollar of assets it reports. Algernon Pharmaceuticals shows a negative utilization of assets of -0.53 percent, losing $0.00526 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Algernon Pharmaceuticals shows how unproductive it operates for each dollar spent on its assets.Algernon Pharmaceuticals Ownership Allocation
Almost 83.57 percent of Algernon Pharmaceuticals outstanding shares are held by general public with 1.7 (percent) owned by insiders and only 14.73 % by other corporate entities.Algernon Pharmaceuticals Profitability Analysis
Net Loss for the year was (6.05 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Algernon Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Algernon Pharmaceuticals and how it compares across the competition.
About Algernon Pharmaceuticals Valuation
The otc valuation mechanism determines Algernon Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Algernon Pharmaceuticals. We calculate exposure to Algernon Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Algernon Pharmaceuticals's related companies.Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Algernon Pharmaceuticals is traded on OTC Exchange in the United States.
8 Steps to conduct Algernon Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Algernon Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Algernon Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Algernon Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Algernon Pharmaceuticals' revenue streams: Identify Algernon Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Algernon Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Algernon Pharmaceuticals' growth potential: Evaluate Algernon Pharmaceuticals' management, business model, and growth potential.
- Determine Algernon Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Algernon Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Algernon Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Algernon Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.4 M | |
| Retained Earnings | -25.2 M |
Complementary Tools for Algernon OTC Stock analysis
When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |